FI105034B - Kristallint etoposid-4'-fosfatdietanolat - Google Patents
Kristallint etoposid-4'-fosfatdietanolat Download PDFInfo
- Publication number
- FI105034B FI105034B FI924359A FI924359A FI105034B FI 105034 B FI105034 B FI 105034B FI 924359 A FI924359 A FI 924359A FI 924359 A FI924359 A FI 924359A FI 105034 B FI105034 B FI 105034B
- Authority
- FI
- Finland
- Prior art keywords
- etoposide
- phosphate
- solution
- crystalline
- diethanolate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (3)
1. Förfarande för framställning av terapeutiskt användbart kristallint etoposid-4'-fosfatdietanolat med 5 formeln (III)
10 H0 0303* i . ,<C,,0,,.,. CHgO^Y^OCHa 15 0P03H2 CIII) 20 kännetecknat av att en mättad lösning av etoposid-4 ' -fosf at bildas i ett etanolhaltigt lösningssystem, ooh kristaller tilläts bildas.
2. Förfarande enligt patentkrav 1, kännetecknat av att nämnda lösningssystem innehäller 9 - ’ : 25 vatten och etanol.
3. Förfarande enligt patentkrav 1, kännetecknat av att nämnda lösningssystem innehäller me-tanol och etanol. t 9 • I
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/773,056 US5648474A (en) | 1991-10-08 | 1991-10-08 | Crystalline etoposide 4'-phosphate diethanolate |
| US77305691 | 1991-10-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI924359A0 FI924359A0 (fi) | 1992-09-29 |
| FI924359A FI924359A (fi) | 1993-04-09 |
| FI105034B true FI105034B (sv) | 2000-05-31 |
Family
ID=25097069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924359A FI105034B (sv) | 1991-10-08 | 1992-09-29 | Kristallint etoposid-4'-fosfatdietanolat |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5648474A (sv) |
| EP (1) | EP0537555B1 (sv) |
| JP (1) | JP3205816B2 (sv) |
| KR (1) | KR100243981B1 (sv) |
| CN (1) | CN1030610C (sv) |
| AT (1) | ATE156832T1 (sv) |
| AU (1) | AU650572B2 (sv) |
| CA (1) | CA2079581C (sv) |
| CZ (1) | CZ283735B6 (sv) |
| DE (1) | DE69221573T2 (sv) |
| DK (1) | DK0537555T3 (sv) |
| EG (1) | EG20187A (sv) |
| ES (1) | ES2109970T3 (sv) |
| FI (1) | FI105034B (sv) |
| GR (1) | GR3025176T3 (sv) |
| HU (2) | HU213606B (sv) |
| IL (1) | IL103262A (sv) |
| MX (1) | MX9205777A (sv) |
| MY (1) | MY108969A (sv) |
| NO (1) | NO178342C (sv) |
| NZ (1) | NZ244521A (sv) |
| PH (1) | PH31666A (sv) |
| PL (1) | PL168332B1 (sv) |
| RU (1) | RU2042686C1 (sv) |
| SK (1) | SK298692A3 (sv) |
| TW (1) | TW239863B (sv) |
| ZA (1) | ZA926903B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459248A (en) * | 1993-11-04 | 1995-10-17 | Bristol-Myers Squibb Company | Process of preparing etoposide phosphate and etoposide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670578A (en) * | 1983-08-29 | 1987-06-02 | Merck & Co., Inc. | Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters |
| US4914222A (en) * | 1983-08-29 | 1990-04-03 | Merck & Co., Inc. | Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process |
| US4713246A (en) * | 1984-03-19 | 1987-12-15 | Bristol-Myers Company | Etoposide oral dosage form |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| US4927638A (en) * | 1986-10-08 | 1990-05-22 | Bristol-Myers Company | Etoposide solutions |
| US4904768A (en) * | 1987-08-04 | 1990-02-27 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
| ES2061891T3 (es) * | 1988-11-16 | 1994-12-16 | Nippon Kayaku Kk | Cristales de dihidrato de dihidrocloruro de compuesto de etoposido-2-dimetilamina y un procedimiento para su produccion. |
| US5081234A (en) * | 1990-04-30 | 1992-01-14 | Bristol-Myers Squibb Co. | 4'-demethylepipodophyllotoxin glycosides |
-
1991
- 1991-10-08 US US07/773,056 patent/US5648474A/en not_active Expired - Lifetime
-
1992
- 1992-03-07 TW TW081101734A patent/TW239863B/zh not_active IP Right Cessation
- 1992-09-10 ZA ZA926903A patent/ZA926903B/xx unknown
- 1992-09-11 MY MYPI92001632A patent/MY108969A/en unknown
- 1992-09-22 JP JP30024092A patent/JP3205816B2/ja not_active Expired - Lifetime
- 1992-09-23 AU AU25301/92A patent/AU650572B2/en not_active Expired
- 1992-09-23 IL IL103262A patent/IL103262A/xx not_active IP Right Cessation
- 1992-09-26 EG EG56692A patent/EG20187A/xx active
- 1992-09-28 NZ NZ244521A patent/NZ244521A/en not_active IP Right Cessation
- 1992-09-28 NO NO923754A patent/NO178342C/no not_active IP Right Cessation
- 1992-09-29 PL PL92296078A patent/PL168332B1/pl unknown
- 1992-09-29 FI FI924359A patent/FI105034B/sv not_active IP Right Cessation
- 1992-09-30 CN CN92111350A patent/CN1030610C/zh not_active Expired - Lifetime
- 1992-09-30 SK SK2986-92A patent/SK298692A3/sk not_active IP Right Cessation
- 1992-09-30 CA CA002079581A patent/CA2079581C/en not_active Expired - Lifetime
- 1992-09-30 CZ CS922986A patent/CZ283735B6/cs not_active IP Right Cessation
- 1992-09-30 DK DK92116749.0T patent/DK0537555T3/da active
- 1992-09-30 EP EP92116749A patent/EP0537555B1/en not_active Expired - Lifetime
- 1992-09-30 ES ES92116749T patent/ES2109970T3/es not_active Expired - Lifetime
- 1992-09-30 RU SU925052958A patent/RU2042686C1/ru active
- 1992-09-30 DE DE69221573T patent/DE69221573T2/de not_active Expired - Lifetime
- 1992-09-30 AT AT92116749T patent/ATE156832T1/de active
- 1992-09-30 PH PH45023A patent/PH31666A/en unknown
- 1992-09-30 HU HU9203119A patent/HU213606B/hu unknown
- 1992-10-01 KR KR1019920018032A patent/KR100243981B1/ko not_active IP Right Cessation
- 1992-10-08 MX MX9205777A patent/MX9205777A/es unknown
-
1995
- 1995-06-22 HU HU95P/P00385P patent/HU211672A9/hu unknown
-
1997
- 1997-10-29 GR GR970402811T patent/GR3025176T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6180781B1 (en) | Process for making mometasone furoate monohydrate | |
| EP0647649B1 (en) | Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative | |
| US8481588B2 (en) | Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan | |
| FI105034B (sv) | Kristallint etoposid-4'-fosfatdietanolat | |
| JP5878864B2 (ja) | ｛［（２ｓ，５ｒ，８ｓ，１１ｓ）−５−ベンジル−１１−（３−グアニジノ−プロピル）−８−イソプロピル−７−メチル−３，６，９，１２，１５−ペンタオキソ−１，４，７，１０，１３−ペンタアザ−シクロペンタデカ−２−イル］−酢酸｝の新規な固体物質およびそれらを得るための方法 | |
| CA2571645A1 (en) | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture | |
| JP3045355B2 (ja) | チオキサンテノン類およびその抗腫瘍剤 | |
| JP2019524654A (ja) | 新しいタイプのタキサン化合物、その製造方法および適用 | |
| EP3455229B1 (en) | Novel crystalline forms | |
| EP0548834B1 (en) | Stable hexahydrate of etoposide 4'-phosphate disodium salt | |
| CA2876454A1 (en) | Bortezomib esters and formulations thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |